Belgium· BE-AMP-SAM390546-00
Forzaten-HCT 40 mg - 10 mg - 25 mg
A olmesartan medoxomil, amlodipin und hydrochlorothiazid product containing olmesartan medoxomil, registered in Belgium by Menarini International Operations Luxembourg. The same ATC class is registered in 9 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Olmesartan medoxomil, amlodipin und hydrochlorothiazid is registered in 9 of 19 countries.
Countries holding a registration under ATC C09DX03 (olmesartan medoxomil, amlodipin und hydrochlorothiazid), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Olmesartan medoxomil, amlodipin und hydrochlorothiazid · ATC C09DX03
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Olmesartan Medoxomil
- Manufacturer
- Menarini International Operations Luxembourg
- Country
- Belgium (BE)
- ATC code
- C09DX03
- ATC class
- Olmesartan medoxomil, Amlodipin und Hydrochlorothiazid
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 3
2 priced- be_apb2837284EUR 19.32
- be_apb2837292EUR 50.19
- be_apb0753368
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
36 interactions on record for olmesartan medoxomil, amlodipin und hydrochlorothiazid.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Olmesartan medoxomil, amlodipin und hydrochlorothiazid · interactions on record
36 records
36 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Olmesartan medoxomil, amlodipin und hydrochlorothiazid in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBenicarCosette Pharmaceuticals, Inc.
- CzechiaSARTENMenarini International Operations Luxembourg S.A., Luxembourg
- ItalyCARDOLS.F. GROUP S.R.L.
- FinlandBenetorMenarini International Operations Luxembourg S.A.
- IrelandOlmesartan Krka 40 mg film-coated tabletsKRKA, d.d., Novo mesto
- FranceALTEIS 40 mg, comprimé pelliculéMENARINI INTERNATIONAL OPERATIONS LUXEMBOURG
- NorwayOlmesartan Medoxomil AccordAccord Healthcare B.V.
- CanadaACH-OLMESARTANACCORD HEALTHCARE INC
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Mencord, Olmeblo
- Bulgaria · Tansidor, Амлосарт
- Cyprus · Olmesartan Medoxomil Jubilant, Olmesartan Tad
- Czechia · Sarten, Zeota
- Germany · Olmecor, Olmes
- Denmark · Olmesartan Medoxomil Krka
- Estonia · Mesar, Olimestra
- Spain · Atolme, Ixia
- Finland · Olmesartan Medoxomil Krka, Olmesartan Medoxomil Stada
- France · Alteis, Olmetec
- United Kingdom (Northern Ireland) · Olmesartan, Olmesartan Glenmark Pharmaceuticals Europe
- Greece · Ipertas, Olmesartan Sandoz
- Croatia · Olimestra, Olmesartan Genericon
- Hungary · Laresin
- Ireland · Olmesartan Krka, Olmesartan Medoxomil Accord Healthcare
- Italy · Cardol, Idalman
- Lithuania · Mesar, Olimestra
- Luxembourg · Belsar, Olmesartan Eg
- Latvia · Mesar, Olimestra
- Malta · Olmesartan Aurobindo Pharma (Malta), Olmesartan Vocate
- Netherlands · Olmesartan Medoxomil Accord, Olmesartan Medoxomil Aurobindo
- Norway · Olmesartan Medoxomil Accord, Olmesartan Medoxomil Krka
- Poland · Olimestra, Olmesartan Lek-Am
- Portugal · Atolme, Condronac
- Romania · Olmetec, Santini
- Slovenia · Olimestra, Tensiol
- Slovakia · Tenzar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c9e35daa-8b5f-4388-bfce-aff24f372e88 GET /v1/drugs/c9e35daa-8b5f-4388-bfce-aff24f372e88?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Forzaten-HCT 40 mg - 10 mg - 25 mg",
"name_fr": "Forzaten-HCT 40 mg - 10 mg - 25 mg",
"name_nl": "Forzaten-HCT 40 mg - 10 mg - 25 mg",
"amp_code": "SAM390546-00",
"strengths": [
"40.0000",
"13.8880",
"10.0000",
"25.0000"
],
"pack_count": 15,
"substances": [
"Olmesartan Medoxomil",
"Amlodipine Besilate",
"Amlodipine",
"Hydrochlorothiazide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide",
"authorisation_numbers": [
"BE390546",
"BE390555"
]
}See everything about olmesartan medoxomil, amlodipin und hydrochlorothiazid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.